Lihong Li
- Reproductive Medicine top 10%
- Ovarian cancer diagnosis and treatment 3
-
- Endometrial and Cervical Cancer Treatments 4
-
- Reproductive System and Pregnancy 2
-
- Cancer Cells and Metastasis 2
-
- Biological and pharmacological studies of plants 3
-
- Ginseng Biological Effects and Applications 2
- Cell death mechanisms and regulation 2
-
- Liver physiology and pathology 2
- Journals
- Brain Research (1 paper)Clinical Cancer Research (1 paper)International Journal of Molecular Sciences (1 paper)
- Partner nations
- ChinaUnited States
In The Last Decade
Lihong Li
27 papers receiving 331 citations
Peers
Comparison fields: 5 of 97
- Reproductive Medicine 49
- Obstetrics and Gynecology 38
- Cancer Research 50
- Immunology 43
- Oncology 53
Countries citing papers authored by Lihong Li
This map shows the geographic impact of Lihong Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lihong Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lihong Li more than expected).
Fields of papers citing papers by Lihong Li
This network shows the impact of papers produced by Lihong Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lihong Li. The network helps show where Lihong Li may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Lihong Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 3 | |
| 2 | 2025 | 2 | |
| 3 | 2024 | 3 | |
| 4 | 2024 | 4 | |
| 5 | 2024 | 0 | |
| 6 | 2023 | 42 | |
| 7 | 2023 | 5 | |
| 8 | 2022 | 1 | |
| 9 | 2022 | 33 | |
| 10 | 2021 | 11 | |
| 11 | 2021 | 11 | |
| 12 | 2021 | 15 | |
| 13 | 2020 | 19 | |
| 14 | 2020 | 16 | |
| 15 | 2020 | 18 | |
| 16 | 2019 | 15 | |
| 17 | 2019 | 1 | |
| 18 | 2016 | 5 | |
| 19 | 2014 | 38 | |
| 20 | 2012 | 25 |
About Lihong Li
Lihong Li is a scholar working on Obstetrics and Gynecology, Reproductive Medicine and Pharmacology, having authored 29 papers that have together received 336 indexed citations. Recurring topics across this work include Endometrial and Cervical Cancer Treatments (4 papers), Biological and pharmacological studies of plants (3 papers), Ovarian cancer diagnosis and treatment (3 papers), Ginseng Biological Effects and Applications (2 papers), Liver physiology and pathology (2 papers), Cancer Cells and Metastasis (2 papers), Cell death mechanisms and regulation (2 papers) and Reproductive System and Pregnancy (2 papers). The work is most often cited by research in Reproductive Medicine (49 citations), Obstetrics and Gynecology (38 citations) and Cancer Research (50 citations). Lihong Li has collaborated with scholars based in China and United States. Frequent co-authors include Tian‐Li Wang, Tengteng Zou, Yu Cai, Tiange Cai, Fengjie Liu, Meng Lan, Mingjiang Liu, Ruijie Xie, Ya Zhang and Guodong Gao. Their work appears in journals such as Brain Research, Clinical Cancer Research and International Journal of Molecular Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.